Comparing fecal immunochemical tests: Improved standardization is needed

Gastroenterology

Volumn 142, Issue 3, 2012, Pages 422-424

  Allison, James E ^a,b   Fraser, Callum G ^c   Halloran, Stephen P ^d   Young, Graeme P ^e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b DIVISION OF RESEARCH   (United States)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

^d UNIVERSITY OF SURREY   (United Kingdom)

^e FLINDERS UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN;

CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; CONCENTRATION (PARAMETERS); FECAL IMMUNOCHEMICAL TEST; FECES ANALYSIS; HEALTH CARE COST; HEALTH CARE SYSTEM; HUMAN; IMMUNOCHEMISTRY; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVIEW; SCREENING TEST; SENSITIVITY AND SPECIFICITY; STANDARDIZATION;

EID: 84857560443     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2012.01.015     Document Type: Editorial

References (20)

1. J.E. Allison, I.S. Tekawa, L.J. Ransom A comparison of fecal occult-blood tests for colorectal-cancer screening N Engl J Med 334 1996 155 159
2. P. Cram, M.A. Fendrick, J. Inadomi The impact of a celebrity promotional campaign on the use of colon cancer screening: the Katie Couric effect Arch Intern Med 163 2003 1601 1605
3. D. Rex, D.A. Johnson, J.C. Anderson Guidelines for colorectal cancer screening 2009 Am J Gastroenterol 104 2009 739 750
4. N.K. Osborn, D.H. Ahlquist Stool screening for colorectal cancer: molecular approaches Gastroenterology 128 2005 192 206
5. B. Levin, D.A. Lieberman, McFarland Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology Gastroenterology 134 2008 1570 1595
6. J.E. Allison The imperative of equal funding for studies that evaluate any of the evidence-based, guideline-recommended colorectal cancer screening tests Clin Gastroenterol Hepatol 7 2009 1269 1271
7. N. Segnan, J. Patnick, L. von Karsa European guidelines for quality assurance in colorectal cancer screening and diagnosis 2010 Publications Office of the European Union Luxembourg http://screening.iarc.fr/doc/ND3210390ENC.pdf
8. Z. Levi, P. Rozen, R. Hazazi A quantitative immunochemical fecal occult blood test for colorectal neoplasia Ann Intern Med 146 2007 244 255
9. D. Park, S. Ryu, Y. Kim Comparison of guaiac-based and quantitative immunochemical fecal occult blood testing in a population at average-risk undergoing colorectal cancer screening Am J Gastroenterol 105 2010 2017 2025
10. T. Morikawa, J. Kato, Y. Yamaji A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population Gastroenterology 129 2005 422 428
11. J.E. Allison, L.C. Sakoda, T.R. Levin Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics J Natl Cancer Inst 99 2007 1462 1470
12. M.J. Denters, M. Deutkom, P.M. Bossuyt Lower risk of advanced neoplasia among patients with a previous negative result from a fecal test for colorectal cancer Gastroenterology 142 2012 497 504
13. R. Harris, L.S. Kinsinger Less is more: not "going the distance" and why J Natl Cancer Inst 103 2011 1726 1728
14. D. Rex, J.L. Petrini, T.H. Baron Quality indicators for colonoscopy Am J Gastroenterol 101 2006 873 885
15. D. Lieberman, M. Nadel, R.A. Smith Standardized colonoscopy reporting and data system: report of the Quality Assurance Task Group of the National Colorectal Cancer Roundtable Gastrointest Endosc 65 2007 757 766
16. N.N. Baxter, M.A. Goldwasser, L.F. Paszat Association of colonoscopy and death from colorectal cancer Ann Intern Med 150 2009 1 8
17. J. Lakoff, L.F. Paszat, R. Saskin Risk of developing proximal versus distal colorectal cancer after a negative colonoscopy: a population-based study Clin Gastroenterol Hepatol 6 2008 1117 1121
18. H. Singh, Z. Nugent, A.A. Demers The reduction in colorectal cancer mortality after colonoscopy varies by site of the cancer Gastroenterology 139 2010 1128 1137
19. H. Brenner, U. Haug, S. Hundt Intertest agreement and quantitative crossvalidation of immunochromatographical fecal occult blood tests Int J Cancer 127 2010 1643 1649
20. S. Hundt, U. Haug, H. Brenner Comparative evaluation of immunochemical fecal occult blood tests for colorectal adenoma detection Ann Intern Med 150 2009 162 169